VIRGIL CRAIG JORDAN to Uterine Neoplasms
This is a "connection" page, showing publications VIRGIL CRAIG JORDAN has written about Uterine Neoplasms.
Connection Strength
0.012
-
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006 Jun 21; 295(23):2727-41.
Score: 0.012